View monthly record counts
| Month | Records |
|---|---|
| 2 |
UVIS ENTERPRISES
SupplierINDIA
A-1-705, PALLADIUM, CORPORATE ROAD ,,MAKARBA, AHMEDABAD,GUJARAT
Data updated:
Top 3 Export Trade Countries
View all on Tradesparq| # | Country / Region | Records |
|---|---|---|
| 1 | Nigeria | 2 |
Top 3 Export HS Codes
View all on Tradesparq| # | HS Code | Description (CN) | Description (EN) | Records |
|---|---|---|---|---|
| 1 | 300490 | 其他混合或非混合产品构成的药品，已配定剂量或制成零售包装 | Other Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, in forms or packings for retail sale | 2 |
Top 3 Export Trading Partners
View all on Tradesparq| # | Partner Name | Country / Region | Records |
|---|---|---|---|
| 1 | GREATLIGHT PHARMACEUTICALS LIMITED | NIGERIA | 2 |
Latest Export Trade Record
View more records on Tradesparq| Date | Mar 09, 2026 | Bill No. | RRHD8Q86T2ZTE | ||
|---|---|---|---|---|---|
| Supplier Information | Company Name | UVIS ENTERPRISES | Buyer Information | Company Name | GREATLIGHT PHARMACEUTICALS LIMITED |
| Address | A-1-705, PALLADIUM, CORPORATE ROAD ,,MAKARBA, | Address | NO.4 ABARABE AVENUE, NOMANSLANDKANO APAPA PORT, LAGOS NIGERIA | ||
| Registration No. | AAGFU1122P | Registration No. | — | ||
| Phone | — | Phone | — | ||
| — | — | ||||
| Product Information | HS Code | 30049099 | HS Description | 其他混合或非混合产品构成的药品，已配定剂量或制成零售包装Other Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, in forms or packings for retail sale | |
| Product Description | PHARMACEUTICAL PRODUCT :- DICLOFENAC POTASSIUM TAB 50 MG (BOXES 10X1X10) | Brand | — | ||
| Quantity & Price | Amount | 26,285.18 | Weight | — | |
| Quantity | 98,000 NOS | TEU | — | ||
| Shipment Information | Origin Country | INDIA | Destination Country | NIGERIA | |
| Port of Loading | NHAVA SHEVA SEA | Destination Port | APAPA | ||
| Loading Place | — | Transport Mode | SEA | ||
| Transaction Mode | — | Carrier | — | ||
| Vessel Name | — | Voyage | — | ||
| Container No. | — | Shipping Country | — | ||